Screening for central nervous system-stimulating drugs in human plasma by liquid chromatography with mass spectrometric detection

Journal of Chromatography A

Volumn 1031, Issue 1-2, 2004, Pages 203-211

  Egge Reubsaet, Jan Leo ^a   Pedersen Bjergaard, Stig ^a  

^a UNIVERSITY OF OSLO   (Norway)

Author keywords

Drugs; Screening

Indexed keywords

BODY FLUIDS; DRUG PRODUCTS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRECIPITATION (CHEMICAL); PROTEINS;

HUMAN PLASMA; MOLECULAR IONS;

NEUROLOGY;

ALPRAZOLAM; ANTIDEPRESSANT AGENT; ANTIHISTAMINIC AGENT; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; BUPRENORPHINE; CHLORDIAZEPOXIDE; CLOBAZAM; CLONAZEPAM; DEXTROPROPOXYPHENE; DIAZEPAM; ESTAZOLAM; FLUNITRAZEPAM; HYDROMORPHONE; KETOBEMIDONE; LORAZEPAM; LORMETAZEPAM; METHADONE; MORPHINE; NEUROLEPTIC AGENT; NITRAZEPAM; OPIATE; OXAZEPAM; OXYCODONE; PENTAZOCINE; PETHIDINE; TEMAZEPAM; TRAMADOL; TRIAZOLAM; UNINDEXED DRUG;

ARTICLE; CENTRAL NERVOUS SYSTEM; DISSOCIATION; EVALUATION; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MOLECULAR DYNAMICS; PRECIPITATION; PRIORITY JOURNAL; SCREENING;

EID: 1342329399     PISSN: 00219673     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chroma.2003.10.057     Document Type: Article

References (19)

1. Kratzsch C., Peters F.T., Kraemer T., Weber A.A., Maurer H.H. J. Mass Spectrom. 38:2003;283.
2. Robson G.M., Ojanpera J.N., Heinonen O.P., Vuori E. Forensic Sci. Int. 121:2001;108.
3. Gergov M., Robson J.N., Duchoslav E., Ojanpera I. J. Mass Spectrom. 35:2000;912.
4. Weinmann W., Lehmann N., Renz M., Weidemann A., Svoboda M. Z. Zagadnien Nauk Sadowych. 42:2000;202.
5. Bogusz M.J. J. Chromatogr. B. 748:2000;3.
6. Spell J.C., Srinivasan K., Syewart J.T., Bartlett M.G. Rapid Commun. Mass Spectrom. 12:1998;890.
7. Garbis S.D., Hanley L., Kalita S. J. AOAC Int. 81:1998;948.
8. Leloux M.S., Niessen W.M.A., Van der Hoeven R.A.M. Biol. Mass Spectrom. 20:1991;647.
9. Moeller M.R., Kraemer T. Therapeutic Drug Monit. 24:2002;210.
10. Skelton H., Dann L.M., Ong R.T.T., Hamilton T., Ilett K.F. Therapeutic Drug Monit. 20:1998;98.
11. Bruins A.P. Mass Spectrom. Rev. 10:1991;53.
12. Schulz M., Schmoldt A. Pharmazie. 52:1997;895.
13. Tamsen A., Bondesson U., Dahlstrøm B., Hartvig P. Clin. Pharmacokinet. 7:1982;252.
14. Cooper S.F., Dugal R., Bertrand M.J. Xenobiotica. 9:1979;405.
15. Samyn N., De Boeck G., Wood M., Lamers C.T.J., De Waard D., Brookhuis K.A., Verstraete A.G., Riedel W.J. Forensic Sci. Int. 128:2002;90.
16. Fouda H.G., Falkner F.C., Hobbs D.C., Luther E.W. Biomed. Mass Spectrom. 5:1978;491.
17. Cook R.F., Bernstein A.D., Arrington T.L., M: Andrews C., Marshall G.A. Int. J. Addict. 30:1995;403.
18. Fendrich M., Johnson T.P., Sudman S., Wislar J.S., Spiehler V. Am. J. Epidemiol. 149:1999;955.
19. Akinci I.H., Tarter R.E., Kirisci L. Addict. Behav. 26:2001;613.